Edwards Lifesciences EW Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's operating lease right-of-use assets in other assets?
- Edwards Lifesciences (EW) reported operating lease right-of-use assets in other assets of $99.3M in Q1 2026.
- How has Edwards Lifesciences's operating lease right-of-use assets in other assets changed year-over-year?
- Edwards Lifesciences's operating lease right-of-use assets in other assets increased by 2.5% year-over-year, from $96.9M to $99.3M.
- What is the long-term trend for Edwards Lifesciences's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Edwards Lifesciences's operating lease right-of-use assets in other assets has grown at a 1.7% compound annual growth rate (CAGR), from $94.2M to $102.7M.